Objectives

After participating in this educational activity, attendees should be able to:

1| Define second generation antiobesity medications and their mechanism of action.
2| Apply core Lifestyle medicine principles to obesity therapy.
3| Illustrate application of Lifestyle medicine principles to practical clinical cases for management of obesity and weight related endocrine conditions


Presenter(s): 

Mahima Gulati, MD

Associate Professor, Division of Endocrinology, Diabetes, and Metabolism

Department of Internal Medicine, 

University of Connecticut Health School of Medicine, 

Farmington, CT

 

Associate Professor (Adjunct)

Department of Medicine

Frank H. Netter School of Medicine

Quinnipiac University

North Haven, CT

 

Director, Lifestyle Medicine Residency curriculum (Internal Medicine residency)

Chief clinical supervisor, Lifestyle Medicine Interest Group, University of Connecticut Health School of Medicine

 

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Mahima Gulati, MD SpeakerNo relevant relationships with ineligible companies to discloseNo

 

Session date: 
11/04/2025 - 12:00pm to 1:00pm EST
Location: 
Webinar
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 ACPE Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 IPCE Credit Hour(s)
Please login or register to take this course.